{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:46Z","timestamp":1786120306948,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1,28]]},"DOI":"10.1097\/qad.0b013e32834f33a2","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T06:19:19Z","timestamp":1323325159000},"page":"295-302","source":"Crossref","is-referenced-by-count":5,"title":["Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users"],"prefix":"10.1097","volume":"26","author":[{"given":"Michelle M.","family":"Estrella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti H.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd T.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek M.","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed G.","family":"Atta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210130","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"R2-5-20210130","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCULATIONAHA.109.898585","article-title":"Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons.","volume":"121","author":"Choi","year":"2010","journal-title":"Circulation"},{"key":"R3-5-20210130","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.2215\/CJN.01030210","article-title":"HIV and proteinuria in an injection drug user population.","volume":"5","author":"Yanik","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R4-5-20210130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1523-1755.2002.00094.x","article-title":"Predictors of proteinuria and renal failure among women with HIV infection.","volume":"61","author":"Szczech","year":"2002","journal-title":"Kidney Int"},{"key":"R6-5-20210130","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/cid\/ciq158","article-title":"Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population.","volume":"52","author":"Dao","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R7-5-20210130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"R8-5-20210130","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3945\/ajcn.110.000976","article-title":"Serum 25-hydroxyvitamin D and parathyroid hormone are independent determinants of whole-body insulin sensitivity in women and may contribute to lower insulin sensitivity in African Americans.","volume":"92","author":"Alvarez","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"R9-5-20210130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1053\/j.jrn.2010.07.002","article-title":"Vitamin d deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions.","volume":"21","author":"Isakova","year":"2011","journal-title":"J Ren Nutr"},{"key":"R10-5-20210130","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1681\/ASN.2009080872","article-title":"Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system.","volume":"21","author":"Zhang","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R11-5-20210130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1677\/JOE-08-0241","article-title":"Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells.","volume":"200","author":"Artaza","year":"2009","journal-title":"J Endocrinol"},{"key":"R12-5-20210130","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1681\/ASN.2009030283","article-title":"25-hydroxyvitamin D levels, race, and the progression of kidney disease.","volume":"20","author":"Melamed","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R13-5-20210130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2007.04.015","article-title":"25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III).","volume":"50","author":"de Boer","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R14-5-20210130","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.ajkd.2009.04.036","article-title":"Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.","volume":"54","author":"Fishbane","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R15-5-20210130","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.","volume":"376","author":"de Zeeuw","year":"2010","journal-title":"Lancet"},{"key":"R16-5-20210130","first-page":"75","article-title":"The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants.","volume":"109","author":"Vlahov","year":"1991","journal-title":"NIDA Res Monogr"},{"key":"R17-5-20210130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"R18-5-20210130","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/clinchem\/31.11.1815","article-title":"Improved radioimmunoassay for vitamin D and its use in assessing vitamin D status.","volume":"31","author":"Hollis","year":"1985","journal-title":"Clin Chem"},{"key":"R19-5-20210130","doi-asserted-by":"crossref","first-page":"2030S","DOI":"10.3945\/jn.110.121483","article-title":"NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary.","volume":"140","author":"Yetley","year":"2010","journal-title":"J Nutr"},{"key":"R20-5-20210130","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archinternmed.2008.604","article-title":"Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004.","volume":"169","author":"Ginde","year":"2009","journal-title":"Arch Intern Med"},{"key":"R21-5-20210130","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/cid\/cir673","article-title":"HIV infection, immune suppression, and uncontrolled viremia are associated with increased multimorbidity among aging injection drug users.","volume":"53","author":"Salter","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R22-5-20210130","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"R23-5-20210130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/QAI.0b013e3181e674f4","article-title":"The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.","volume":"55","author":"Estrella","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R24-5-20210130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/QAD.0b013e3283359253","article-title":"Kidney function and the risk of cardiovascular events in HIV-1-infected patients.","volume":"24","author":"George","year":"2010","journal-title":"AIDS"},{"key":"R25-5-20210130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00002030-200402200-00022","article-title":"Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study.","volume":"18","author":"Lucas","year":"2004","journal-title":"AIDS"},{"key":"R26-5-20210130","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1097\/QAD.0b013e3283313c91","article-title":"HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy.","volume":"23","author":"Choi","year":"2009","journal-title":"AIDS"},{"key":"R27-5-20210130","doi-asserted-by":"crossref","first-page":"15896","DOI":"10.1073\/pnas.0803751105","article-title":"Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R28-5-20210130","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ki.2010.22","article-title":"Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes.","volume":"77","author":"Deb","year":"2010","journal-title":"Kidney Int"},{"key":"R29-5-20210130","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1464-5491.2003.00979.x","article-title":"The renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations.","volume":"20","author":"Gilbert","year":"2003","journal-title":"Diabet Med"},{"key":"R30-5-20210130","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1043-2760(03)00111-5","article-title":"The intrarenal renin-angiotensin system and diabetic nephropathy.","volume":"14","author":"Carey","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"R31-5-20210130","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1046\/j.1523-1755.2000.00879.x","article-title":"Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.","volume":"57","author":"Chan","year":"2000","journal-title":"Kidney Int"},{"key":"R32-5-20210130","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"R33-5-20210130","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1172\/JCI119000","article-title":"Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver.","volume":"98","author":"Veniant","year":"1996","journal-title":"J Clin Invest"},{"key":"R34-5-20210130","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1056\/NEJMcibr1008395","article-title":"Proteinuria, the podocyte, and insulin resistance.","volume":"363","author":"Fornoni","year":"2010","journal-title":"N Engl J Med"},{"key":"R35-5-20210130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cmet.2010.08.015","article-title":"Insulin signaling to the glomerular podocyte is critical for normal kidney function.","volume":"12","author":"Welsh","year":"2010","journal-title":"Cell Metab"},{"key":"R36-5-20210130","doi-asserted-by":"crossref","first-page":"F526","DOI":"10.1152\/ajprenal.00316.2003","article-title":"1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat.","volume":"286","author":"Kuhlmann","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"R38-5-20210130","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/ki.2008.453","article-title":"Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation.","volume":"74","author":"Zehnder","year":"2008","journal-title":"Kidney Int"},{"key":"R39-5-20210130","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1523-1755.2005.00562.x","article-title":"1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression.","volume":"68","author":"Li","year":"2005","journal-title":"Kidney Int"},{"key":"R40-5-20210130","doi-asserted-by":"crossref","first-page":"F734","DOI":"10.1152\/ajprenal.00415.2009","article-title":"HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation.","volume":"298","author":"Yadav","year":"2010","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-201201280-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:28:51Z","timestamp":1786048131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201201280-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,28]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32834f33a2","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1,28]]}}}